Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials
The Pharma Data
MAY 17, 2021
Regeneron resumes enrollment in lymphoma drug trials ( Reuters ). Incyte’s vitiligo treatment meets main goal in late-stage trial ( Reuters ). No To Five, Yes To Three: NICE Decides On Funding For Drugs In England ( Pink Sheet ). Trump tax law cut what US drugmakers owed.
Let's personalize your content